- Home
- MLM vs TAK Comparison
MLM vs TAK Comparison
Compare MLM & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLM | TAK |
|---|---|---|
| Founded | 1993 | 1781 |
| Country | United States | Japan |
| Employees | 9400 | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9B | 43.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLM | TAK |
|---|---|---|
| Price | $645.60 | $15.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $656.36 | N/A |
| AVG Volume (30 Days) | 390.2K | ★ 2.5M |
| Earning Date | 02-11-2026 | 01-29-2026 |
| Dividend Yield | 0.51% | ★ 3.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 18.97 | 0.14 |
| Revenue | $6,903,000,000.00 | ★ $29,846,840,032.00 |
| Revenue This Year | $1.41 | N/A |
| Revenue Next Year | $8.43 | $0.47 |
| P/E Ratio | ★ $33.09 | $219.74 |
| Revenue Growth | ★ 17.84 | N/A |
| 52 Week Low | $441.95 | $12.80 |
| 52 Week High | $665.18 | $15.69 |
Technical Indicators
Market Signals| Indicator | MLM | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 62.91 | 78.41 |
| Support Level | $610.32 | $14.43 |
| Resistance Level | $639.49 | $14.66 |
| Average True Range (ATR) | 12.70 | 0.17 |
| MACD | 2.01 | 0.13 |
| Stochastic Oscillator | 99.09 | 99.66 |
Price Performance
Historical ComparisonAbout MLM Martin Marietta Materials Inc.
Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2024, Martin Marietta sold 191 million tons of aggregates. Martin Marietta's most important markets include Texas, North Carolina, Colorado, California, and Georgia, accounting for most of its sales. The company also uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.